Christopher Hartl is a CTO and bioinformatics leader with 14 years of experience translating complex genomics and multi-omic research into production-ready analytics and diagnostic products. He has progressed from computational roles at the Broad Institute and UCLA to technical leadership at Epigenome Technologies and Rancho BioSciences, building data platforms, ML pipelines, and ontologically driven databases for single-cell and bulk sequencing. His work spans developing scalable cloud deployment for clinical-grade assays, statistical methods for rare-variant association, and bespoke libraries for single-cell coexpression and receptor–ligand inference. Christopher pairs rigorous academic training (PhD in Bioinformatics, UCLA; BA in Applied Mathematics, Harvard) with hands-on engineering—authoring tools that processed hundreds of millions of flow-cytometry events and automated genome assembly/annotation workflows. He is known for shrinking analytical bottlenecks via novel statistical approaches and for estimating diagnostic yield to guide product strategy, bringing a rare combination of research depth and product-focused execution.
14 years of coding experience
8 years of employment as a software developer
BA Applied Mathematics, BA Applied Mathematics at Harvard University
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.
Request Free Trial
Christopher Hartl - Chief Technology Officer at Rancho BioSciences